Addison’s disease and hypertransaminasemia

References

• Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology123(4), 1367–1384 (2002).
   PubMed Web of Science ®Google Scholar
• Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N. Engl. J. Med.342(17), 1266–1271 (2000).
   PubMed Web of Science ®Google Scholar
• Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ172(3), 367–379 (2005).
   PubMed Web of Science ®Google Scholar
• Salmela PI, Sotaniemi EA, Niemi M, Maentausta O. Liver function tests in diabetic patients. Diabetes Care7(3), 248–254 (1984).
   PubMed Web of Science ®Google Scholar
• Babb RR. Associations between diseases of the thyroid and the liver. Am. J. Gastroenterol.79(5), 421–423 (1984).
   PubMedGoogle Scholar
• Neufeld M, Maclaren N, Blizzard R. Autoimmune polyglandular syndromes. Pediatr. Ann.9(4), 154–162 (1980).
   PubMed Web of Science ®Google Scholar
• Michele TM, Fleckenstein J, Sgrignoli AR, Thuluvath PJ. Chronic active hepatitis in the type I polyglandular autoimmune syndrome. Postgrad. Med. J.70(820), 128–131 (1994).
   PubMedGoogle Scholar
• Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med.322(26), 1829–1836 (1990).
   PubMed Web of Science ®Google Scholar
• Elfstrom P, Montgomery SM, Kampe O, Ekbom A, Ludvigsson JF. Risk of primary adrenal insufficiency in patients with celiac disease. J. Clin. Endocrinol. Metab.92(9), 3595–3598 (2007).
   PubMed Web of Science ®Google Scholar
• Duggan JM, Duggan AE. Systematic review: the liver in coeliac disease. Aliment Pharmacol. Ther.21(5), 515–518 (2005).
   PubMed Web of Science ®Google Scholar
• Olsson RG, Lindgren A, Zettergren L. Liver involvement in Addison’s disease. Am. J. Gastroenterol.85(4), 435–438 (1990).
   PubMed Web of Science ®Google Scholar
• Boulton R, Hamilton MI, Dhillon AP, Kinloch JD, Burroughs AK. Subclinical Addison’s disease: a cause of persistent abnormalities in transaminase values. Gastroenterology109(4), 1324–1327 (1995).
   PubMed Web of Science ®Google Scholar
• Lesur G, Barete S, Le Parc JM, Dupay P, Paolaggi JB. [Addison disease: a rare cause of elevated serum aminotransferase activity]. Gastroenterol. Clin. Biol.20(5), 515–516 (1996).
   PubMedGoogle Scholar
• Castiella A, Etxeberria X, Ganzarain J, Aramburu V. Hypertransaminasaemia and Addison’s disease. Eur. J. Gastroenterol. Hepatol.10(10), 891–892 (1998).
   PubMedGoogle Scholar
• Rizvi AA, Kerrick JG. Liver involvement and abnormal iron variables in undiagnosed Addison’s disease. Endocr. Pract.7(3), 184–188 (2001).
   PubMedGoogle Scholar
• Roblin X, Boudemaghe T, Le Gall S, Esterni JP, Pellissier L. Use of the Synacthene test in the assessment of aminotransferase elevation. J. Hepatol.36(1), 139–140 (2002).
   PubMedGoogle Scholar
• Milionis HJ, Dimos GA, Tsiara S, Tsatsoulis A, Tsianos EV, Elisaf MS. Unexplained hypertransaminasaemia: clue to diagnosis of Addison’s disease. Eur. J. Gastroenterol. Hepatol.14(11), 1285–1286 (2002).
   PubMedGoogle Scholar
• Gurakuqi GC, Stadlbauer V, Stepan V, Warnkross H, Trauner M. [Addison’s disease as a rare cause of chronically elevated liver enzymes]. Z. Gastroenterol.44(2), 179–183 (2006).
   PubMed Web of Science ®Google Scholar
• Ersan O, Demirezer B. Addison’s disease: a rare cause of hypertransaminasaemia. Dig. Dis. Sci.53(12), 3269–3271 (2008).
   PubMedGoogle Scholar
• Oelkers W. Adrenal insufficiency. N. Engl. J. Med.335(16), 1206–1212 (1996).
   PubMed Web of Science ®Google Scholar
• Burke CW. Adrenocortical insufficiency. Clin. Endocrinol. Metab.14(4), 947–976 (1985).
   PubMedGoogle Scholar
• Betterle C, Scalici C, Presotto F et al. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J. Endocrinol.117(3), 467–475 (1988).
   PubMed Web of Science ®Google Scholar
• Nerup J. Addison’s disease – a review of some clinical, pathological and immunological features. Dan. Med. Bull.21(6), 201–217 (1974).
   PubMed Web of Science ®Google Scholar
• Martin Martorell P, Roep BO, Smit JW. Autoimmunity in Addison’s disease. Neth. J. Med.60(7), 269–275 (2002).
   PubMedGoogle Scholar
• Freeman M, Weetman AP. T and B cell reactivity to adrenal antigens in autoimmune Addison’s disease. Clin. Exp. Immunol.88(2), 275–279 (1992).
   PubMedGoogle Scholar
• Uibo R, Aavik E, Peterson P et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison‘s disease. J. Clin. Endocrinol. Metab.78(2), 323–328 (1994).
   PubMedGoogle Scholar
• Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kampe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison’s disease. J. Clin. Invest.92(5), 2377–2385 (1993).
   PubMed Web of Science ®Google Scholar
• Perheentupa J. Autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED). Horm. Metab. Res.28(7), 353–356 (1996).
   PubMedGoogle Scholar
• Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison’s disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore)60(5), 355–362 (1981).
   PubMed Web of Science ®Google Scholar
• Peterson P, Nagamine K, Scott H et al. APECED: a monogenic autoimmune disease providing new clues to self-tolerance. Immunol. Today19(9), 384–386 (1998).
   PubMedGoogle Scholar
• Finnish–German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat. Genet.17(4), 399–403 (1997).
   PubMed Web of Science ®Google Scholar
• Nagamine K, Peterson P, Scott HS et al. Positional cloning of the APECED gene. Nat. Genet.17(4), 393–398 (1997).
   PubMed Web of Science ®Google Scholar
• Buzi F, Badolato R, Mazza C et al. Autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy syndrome: time to review diagnostic criteria? J. Clin. Endocrinol. Metab.88(7), 3146–3148 (2003).
   PubMedGoogle Scholar
• Smith D, Stringer MD, Wyatt J et al. Orthotopic liver transplantation for acute liver failure secondary to autoimmune hepatitis in a child with autoimmune polyglandular syndrome type 1. Pediatr. Transplant.6(2), 166–170 (2002).
   PubMedGoogle Scholar
• Clemente MG, Obermayer-Straub P, Meloni A et al. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J. Clin. Endocrinol. Metab.82(5), 1353–1361 (1997).
   PubMed Web of Science ®Google Scholar
• Ahonen P, Miettinen A, Perheentupa J. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J. Clin. Endocrinol. Metab.64(3), 494–500 (1987).
   PubMedGoogle Scholar
• Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology119(1), 234–242 (2000).
   PubMed Web of Science ®Google Scholar
• Catassi C, Ratsch IM, Fabiani E et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet343(8891), 200–203 (1994).
   PubMed Web of Science ®Google Scholar
• Green PH, Jabri B. Coeliac disease. Lancet362(9381), 383–391 (2003).
   PubMed Web of Science ®Google Scholar
• Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology120(3), 636–651 (2001).
   PubMed Web of Science ®Google Scholar
• Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology117(2), 297–303 (1999).
   PubMed Web of Science ®Google Scholar
• Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr. Rev.23(3), 327–364 (2002).
   PubMed Web of Science ®Google Scholar
• O’Leary C, Walsh CH, Wieneke P et al. Coeliac disease and autoimmune Addison’s disease: a clinical pitfall. QJM95(2), 79–82 (2002).
   PubMed Web of Science ®Google Scholar
• Myhre AG, Aarsetoy H, Undlien DE, Hovdenak N, Aksnes L, Husebye ES. High frequency of coeliac disease among patients with autoimmune adrenocortical failure. Scand. J. Gastroenterol.38(5), 511–515 (2003).
   PubMed Web of Science ®Google Scholar
• Betterle C, Lazzarotto F, Spadaccino AC et al. Celiac disease in North Italian patients with autoimmune Addison’s disease. Eur. J. Endocrinol.154(2), 275–279 (2006).
   PubMed Web of Science ®Google Scholar
• Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease – associated disorders and survival. Gut35(9), 1215–1218 (1994).
   PubMed Web of Science ®Google Scholar
• Soderbergh A, Myhre AG, Ekwall O et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab.89(2), 557–562 (2004).
   PubMed Web of Science ®Google Scholar
• Betterle C, Greggio NA, Volpato M. Clinical review 93: autoimmune polyglandular syndrome type 1. J. Clin. Endocrinol. Metab.83(4), 1049–1055 (1998).
   PubMed Web of Science ®Google Scholar
• Trence DL, Morley JE, Handwerger BS. Polyglandular autoimmune syndromes. Am. J. Med.77(1), 107–116 (1984).
   PubMed Web of Science ®Google Scholar
• Lintas C, Cappa M, Comparcola D, Nobili V, Fierabracci A. An 8-year-old boy with autoimmune hepatitis and Candida onychosis as the first symptoms of autoimmune polyglandular syndrome (APS1): identification of a new homozygous mutation in the autoimmune regulator gene (AIRE). Eur. J. Pediatr.167(8), 949–953 (2008).
   PubMedGoogle Scholar
• Lankisch TO, Strassburg CP, Debray D, Manns MP, Jacquemin E. Detection of autoimmune regulator gene mutations in children with type 2 autoimmune hepatitis and extrahepatic immune-mediated diseases. J. Pediatr.146(6), 839–842 (2005).
   PubMedGoogle Scholar
• Kogawa K, Kudoh J, Nagafuchi S et al. Distinct clinical phenotype and immunoreactivity in Japanese siblings with autoimmune polyglandular syndrome type 1 (APS-1) associated with compound heterozygous novel AIRE gene mutations. Clin. Immunol.103(3 Pt 1), 277–283 (2002).
   PubMedGoogle Scholar
• Bergwitz C, Brabant G, Trautwein C, Manns MP. A patient with autoimmune hepatitis type I, Addison‘s disease, atrophic thyroiditis, atrophic gastritis, exocrine pancreatic insufficiency, and heterozygous α1-antitrypsin deficiency. Am. J. Gastroenterol.97(4), 1050–1052 (2002).
   PubMedGoogle Scholar
• Perniola R, Falorni A, Clemente MG, Forini F, Accogli E, Lobreglio G. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED). Eur. J. Endocrinol.143(4), 497–503 (2000).
   PubMed Web of Science ®Google Scholar
• Clemente MG, Meloni A, Obermayer-Straub P, Frau F, Manns MP, De Virgiliis S. Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology114(2), 324–328 (1998).
   PubMed Web of Science ®Google Scholar
• Goldstein NS, Rosenthal P, Sinatra F, Dehner LP. Liver disease in polyglandular autoimmune disease type one: clinicopathologic study of three patients and review of the literature. Pediatr. Pathol. Lab. Med.16(4), 625–636 (1996).
   PubMed Web of Science ®Google Scholar
• Krawitt EL. Autoimmune hepatitis. N. Engl. J. Med.354(1), 54–66 (2006).
   PubMed Web of Science ®Google Scholar
• Arulanantham K, Dwyer JM, Genel M. Evidence for defective immunoregulation in the syndrome of familial candidiasis endocrinopathy. N. Engl. J. Med.300(4), 164–168 (1979).
   PubMed Web of Science ®Google Scholar
• Obermayer-Straub P, Perheentupa J, Braun S et al. Hepatic autoantigens in patients with autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy. Gastroenterology121(3), 668–677 (2001).
   PubMed Web of Science ®Google Scholar
• McFarlane IG. Definition and classification of autoimmune hepatitis. Semin. Liver Dis.22(4), 317–324 (2002).
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Manns MP. Autoantibodies and autoantigens in autoimmune hepatitis. Semin. Liver Dis.22(4), 339–352 (2002).
   PubMed Web of Science ®Google Scholar
• Husebye ES, Gebre-Medhin G, Tuomi T et al. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab.82(1), 147–150 (1997).
   PubMed Web of Science ®Google Scholar
• Gebre-Medhin G, Husebye ES, Gustafsson J et al. Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Lett.412(3), 439–445 (1997).
   PubMedGoogle Scholar
• Viru A, Litvinova L, Viru M, Smirnova T. Glucocorticoids in metabolic control during exercise: alanine metabolism. J. Appl. Physiol.76(2), 801–805 (1994).
   PubMed Web of Science ®Google Scholar
• Omagari K, Masuda J, Kato Y et al. Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group. Intern. Med.39(12), 1008–1012 (2000).
   PubMedGoogle Scholar
• Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J. Hepatol.31(5), 929–938 (1999).
   PubMed Web of Science ®Google Scholar
• Choudhuri K, Gregorio GV, Mieli-Vergani G, Vergani D. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis. Hepatology28(5), 1177–1181 (1998).
   PubMedGoogle Scholar